The Rebel Who Prefers a Cancer-Free Future, Not Fame
When we last spoke with Tim Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was still a relatively small outfit with only 17 employees. But since then, the venture has undergone a remarkable transformation. The company is now part of a massive cluster of blockbuster biotech drugs that are losing patent protection in roughly the same window, creating new opportunities for investment and growth.
The tech industry's shift towards AI has also had a profound impact on Jobs' views. He sees AI as a crucial component of Yosemite's strategy, and believes it holds the key to unlocking significant advances in various fields. In his own words, "I didn't expect Yosemite to be moving this fast," suggesting that the company's rapid progress is more than just a coincidence.
As Jobs looks out at his team, he seems to have found a sense of purpose and fulfillment that goes beyond personal fame or recognition. With AI on its side, Yosemite is poised to capitalize on new opportunities in areas like genomics and personalized medicine, and Jobs' vision for the future appears increasingly clear: a cancer-free world where technology plays an essential role in improving human health.